SHH and neoplasm: These genomic data will provide a more comprehensive picture of the molecular scenario regarding the players driving tumor progression and will help to find ways to target those genes, thus increasing the probability of suppressing tumor progression and/or reversing the pro-malignancy effects of SHH secretion by tumor-associated astrocytes.